Long-term Results of 185 Consecutive Osseointegrated Hearing Device Implantations: A Comparison Among Children, Adults, and Elderly

TY - JOUR

T1 - Long-term Results of 185 Consecutive Osseointegrated Hearing Device Implantations

T2 - A Comparison Among Children, Adults, and Elderly

AU - Calvo Bodnia, Nadia

AU - Foghsgaard, Søren

AU - Nue Møller, Martin

AU - Cayé-Thomasen, Per

PY - 2014/12/10

Y1 - 2014/12/10

N2 - OBJECTIVE: To determine the occurrence and type of perioperative and postoperative complications in patients implanted with an osseointegrated hearing device (OHD) (also known as BAHA/BAHS) and compare results in children, adults, and elderly and for different surgical techniques.STUDY DESIGN: Retrospective case file review.SETTING: Tertiary referral center.PATIENTS: Patients implanted with an OHD between 2004 and 2012, with more than 6 months of follow-up.INTERVENTION: OHD implantation.MAIN OUTCOME MEASURES: Implant loss, adverse skin reactions (Holgers' score, ≥2), skin overgrowth, and discomfort resulting in abutment and/or implant removal.RESULTS: One hundred eighty-five implantations in 176 patients were reviewed. Overall, 3.8% of the implants were lost spontaneously after a mean of 2.5 years. Implant loss in children was 18% versus 2.5% in adults and 3.8% in elderly. Adverse skin reactions occurred in 14% of observations overall; in 10% in children compared with 16% in adults and 9% in elderly. Partial or total skin overgrowth was seen in 4% and 6% of the observations in children and adults, respectively, whereas none of the elderly experienced this problem. The abutment was removed because of discomfort and/or no benefit in 10% overall, in 13% of adults, and in 6% of the elderly; none of the children opted for removal. Linear incision technique showed fewest complications.CONCLUSION: OHD implantation is a procedure with few major complications. Adverse skin reaction is the most common complication. Children lose the implant more frequently than adults. Elderly patients have less adverse skin reactions/skin overgrowth. Discomfort leading to abutment removal is a concern especially among adults.

AB - OBJECTIVE: To determine the occurrence and type of perioperative and postoperative complications in patients implanted with an osseointegrated hearing device (OHD) (also known as BAHA/BAHS) and compare results in children, adults, and elderly and for different surgical techniques.STUDY DESIGN: Retrospective case file review.SETTING: Tertiary referral center.PATIENTS: Patients implanted with an OHD between 2004 and 2012, with more than 6 months of follow-up.INTERVENTION: OHD implantation.MAIN OUTCOME MEASURES: Implant loss, adverse skin reactions (Holgers' score, ≥2), skin overgrowth, and discomfort resulting in abutment and/or implant removal.RESULTS: One hundred eighty-five implantations in 176 patients were reviewed. Overall, 3.8% of the implants were lost spontaneously after a mean of 2.5 years. Implant loss in children was 18% versus 2.5% in adults and 3.8% in elderly. Adverse skin reactions occurred in 14% of observations overall; in 10% in children compared with 16% in adults and 9% in elderly. Partial or total skin overgrowth was seen in 4% and 6% of the observations in children and adults, respectively, whereas none of the elderly experienced this problem. The abutment was removed because of discomfort and/or no benefit in 10% overall, in 13% of adults, and in 6% of the elderly; none of the children opted for removal. Linear incision technique showed fewest complications.CONCLUSION: OHD implantation is a procedure with few major complications. Adverse skin reaction is the most common complication. Children lose the implant more frequently than adults. Elderly patients have less adverse skin reactions/skin overgrowth. Discomfort leading to abutment removal is a concern especially among adults.

U2 - 10.1097/MAO.0000000000000543

DO - 10.1097/MAO.0000000000000543

M3 - Journal article

C2 - 25122598

SN - 1531-7129

VL - 35

SP - e301–e306

JO - Otology & Neurotology

JF - Otology & Neurotology

IS - 10

ER -